161 related articles for article (PubMed ID: 37816248)
1. Amelioration of Tumor-promoting Microenvironment via Vascular Remodeling and CAF Suppression Using E7130: Biomarker Analysis by Multimodal Imaging Modalities.
Ito K; Yamaguchi M; Semba T; Tabata K; Tamura M; Aoyama M; Abe T; Asano O; Terada Y; Funahashi Y; Fujii H
Mol Cancer Ther; 2024 Feb; 23(2):235-247. PubMed ID: 37816248
[TBL] [Abstract][Full Text] [Related]
2. First-in-human study of E7130 (a tumor microenvironment-ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose-escalation part.
Doi T; Matsubara N; Naito Y; Kuboki Y; Harano K; Ono M; Urasaki T; Ohmoto A; Kawanai T; Hisai T; Ikezawa H; Shiba S; Ito K; Semba T; Asano O; Takahashi S
Cancer; 2023 Aug; 129(15):2348-2359. PubMed ID: 37080942
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
4. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
[TBL] [Abstract][Full Text] [Related]
7. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
9. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
10. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
[No Abstract] [Full Text] [Related]
11. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
12. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden D; Zaheer S; Ahluwalia H; Ranga S
Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation.
Yao L; Hou J; Wu X; Lu Y; Jin Z; Yu Z; Yu B; Li J; Yang Z; Li C; Yan M; Zhu Z; Liu B; Yan C; Su L
Redox Biol; 2023 Nov; 67():102923. PubMed ID: 37832398
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.
Zeltz C; Primac I; Erusappan P; Alam J; Noel A; Gullberg D
Semin Cancer Biol; 2020 May; 62():166-181. PubMed ID: 31415910
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
17. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
[TBL] [Abstract][Full Text] [Related]
18. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
[TBL] [Abstract][Full Text] [Related]
19. CD248
Xu C; Zhang K; Yang F; Zhou X; Liu S; Li Y; Ma S; Zhao X; Lu T; Lu S; Zhang J; Li H; Han D; Wen W; Qin W
Front Oncol; 2021; 11():773063. PubMed ID: 34970489
[TBL] [Abstract][Full Text] [Related]
20. Force-dependent extracellular matrix remodeling by early-stage cancer cells alters diffusion and induces carcinoma-associated fibroblasts.
Jung WH; Yam N; Chen CC; Elawad K; Hu B; Chen Y
Biomaterials; 2020 Mar; 234():119756. PubMed ID: 31954229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
